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Abstract of Thesis 
 
Excitotoxicity can lead to increases in intracellular Na+ and Ca2+ concentrations via the 
glutamatergic NMDA receptors, which can lead to cell death.  Detailing the time-
dependent degradation of neuronal components in response to excitotoxic challenge may 
help elucidate the sequence in which these signaling pathways are initiated and further, 
associate these pathways with topographic cellular demise.  Using organotypic 
hippocampal slice culture technique, tissue from neonatal rat pups was exposed to 
NMDA, APV, or co-exposed for 24, 72 or 120 hours.  Fluorescent microscopy of 
propidium iodide (PI) was used to evaluate neuronal membrane damage, changes in the 
density of mature soma (NeuN) and NMDA NR2B subunits were measured using 
immunohistochemical procedures.  After 24 hours of exposure, the CA1 showed an 
increased PI signal and a decrease in NeuN marker, indicating somatic injury occurs 
shortly after excitotoxic challenge; these effects were blocked by co-administration of 
APV. Also in the CA1, loss of NR2B subunits, heavily expressed in dendritic processes, 
declined following 72 hours of exposure.  Because somatic injury precedes loss of distal 
NR2B subunits, it is possible that these events involve different mechanisms, findings 
that may be relevant in the development of therapies to target neurodegeneration resulting 
from excitotoxicity. 
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Chapter One: Introduction  
     
Excitotoxicity 
Glutamate is the most abundant excitatory neurotransmitter found in the 
mammalian central nervous system (CNS).  The activation of glutamatergic receptors is a 
crucial component in the proliferation, maintenance, and survival of neurons (Cooper et. 
al., 2003; Hardingham & Bading, 2003).  However, when neurons are chronically 
exposed to glutamate or exposed to excessive concentrations of the neurotransmitter, they 
can become over stimulated, a condition defined by Olney as excitotoxicity (Choi, 1992; 
Olney, 1986).  Conditions suspected to involve glutamate induced excitotoxicity include 
alcohol withdrawal (Prendergast et al., 2004), hypoxia-ischemia (Hertz 2008), epilepsy 
(Olney et al, 1998), traumatic brain injury (TBI) (Hardingham & Bading, 2003) and 
neurodegenerative diseases including Alzheimer’s (Albensi et al, 2004; Dong et al, 
2009).  Excitotoxicity can lead to the swelling of the cell, loss of cellular components via 
activation of multiple signaling pathways including proteases, lipases, and the disruption 
of mitochondrial membrane potential, all of which can culminate in cell death (Albensi, 
2007; Choi et. al., 1987; Forder, 2009; Hardingham & Bading, 2003).   The following 
research sought to detail the time-dependent degradation of neuronal components in 
response to excitotoxic challenge in order to elucidate the sequence in which signaling 
pathways are initiated and further, associate these pathways with topographic cellular 
demise.   This temporal and topographical mapping may identify crucial mechanisms in 
the death cascade, which could then be targeted to halt the neurodegeneration that results 
from excitotoxicity.    
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 Glutamate Mediated Calcium Activity 
Cell Membrane Permeability to Calcium Ions 
Glutamate induced excitotoxicity is a calcium (Ca2+) mediated event in which 
intracellular Ca2+ concentrations increase to toxic levels from which the cell cannot 
recover.  There is a 10,000 fold Ca2+ concentration gradient across the plasma membrane, 
with concentrations around 1-2 mM outside the cell and between 10-100 nM in the 
cytoplasm (Marcoux & Choi 2002; Dingledine, et al., 1999).  A key component in Ca2+ 
regulation is the plasma membrane calcium-ATPase (PMCA) (Choi, 1992; Dingledine, et 
al., 1999).  The PMCA transports Ca2+ from the cytosol into the extracellular space and is 
regulated by several intracellular signaling pathways.  However, because the PMCA is a 
high affinity but low capacity transporter, its main role is to regulate Ca2+ concentration 
when the cell is at rest.  Following a depolarizing event, it is the fast acting Na+/Ca2+ 
exchanger that is capable of moving large amounts of Ca2+ into the extracellular space 
(Feldman et al, 1996).  The Na+/K+ -ATPase also works to reset Ca2+ levels, though more 
indirectly.  By resetting the cells membrane to its resting potential, thereby inhibiting 
depolarization, the Na+/K+ -ATase makes the membrane less permeable to Ca2+ influx via 
voltage-dependent calcium channels (VDCC) and N-methyl-D-aspartate (NMDA) 
receptors (Cooper et. al., 2003).  Gamma-aminobutyric acid (GABA) receptors also 
contribute to stabilizing the plasma membrane and reducing Ca2+ permeability by 
inhibiting depolarizing events (Cooper et. al., 2003).  The effects of Na+ coupled 
glutamate transporters located on astrocytes also help protect the cell from excitotoxicity 
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by removing glutamate from the synaptic cleft, thereby limiting its ability to affect 
postsynaptic membrane calcium permeability (Marcoux & Choi 2002).   
 
Intracellular Reaction to Increases in Calcium Ions 
Once cytosolic Ca2+ levels have increased beyond physiological levels, the 
endoplasmic reticulum (ER) and mitochondria, two major organelles critical to cellular 
function, can become compromised.  The ER is continually transporting cytosolic Ca2+ 
across its membrane by means of the smooth ER Ca2+ATP-ase (SERCA) to maintain a 
100 fold higher Ca2+ concentration inside the ER than in the cytosol (Marcoux & Choi 
2002).  The ER membrane also has two ligand gated Ca2+ channels, inositol trisphosphate 
(IP3) and ryanodine receptors, which mediate the release of Ca2+ stores from the ER.   
The IP3 receptor is activated when bound by IP3, which is released in response to G-
protein coupled glutamate receptor activation.  The ryanodine receptor is activated in 
response to elevated intracellular Ca2+ concentrations (Marcoux & Choi 2002).  
Activation of these receptors not only increases cytosolic Ca2+ concentrations, but can 
also lead to ER stress.  This stress can release ER membrane bound caspase-12, which in 
turn can activate executioner caspases, which induce apoptosis (Dingledine, et al., 1999).   
The mitochondria are also sensitive to disruptions in Ca2+ homeostasis.  During 
times of normal activity, mitochondrial Ca2+ concentrations are ~100nM (Dingledine, et 
al., 1999).  However, upon influx of Ca2+ (ie, activation of glutamatergic receptors) 
mitochondria function as a buffer, rapidly moving ions down an electrochemical gradient 
via a uniporter, into the mitochondria (Bernardi & Rasola 2007).  In addition, 
mitochondria possess a Na+ /Ca2+ exchanger that functions bi-directionally in reaction to 
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physiological or pathological conditions.   Despite these dynamic mechanisms, 
mitochondria can become compromised under high intracellular Ca2+ concentrations and 
mitochondrial permeability transition pores (mPTP) can develop, a topic reviewed by 
Crompton (1999).  The formation of these pores can lead to cell death by either necrosis 
or apoptosis.  mPTP can permanently disrupt mitochondrial homeostasis and therefore, 
the synthesis of ATP.  Once a cell can no longer generate ATP, overall cell homeostasis 
is compromised and necrosis can ensue (Crompton 1999; Dingledine, et al., 1999).  
mPTP formation can also allow the release of several apoptotic molecules, initiating 
either caspase-dependent or -independent pathways.  The former pathway is initiated with 
cytochrome c (cyt c) release through mPTP; the latter is initiated by the release of 
apoptosis-inducing factor (AIF) through mPTP (Crompton 1999; Dingledine, et al., 1999, 
Renolleau et al, 2008).    
 
Glutamate Receptors and Excitotoxicity 
 Glutamate receptors are referred to as excitatory amino acid transmitters (EAA) 
and can be classified into two categories, metabotropic and ionotropic; both are involved 
in glutamate mediated excitotoxicity.  The metabotropic glutamate receptor (mGluR) 
family is distinct from ionotropic EAA receptors in that they are linked to G proteins and 
bring about intracellular changes via second messenger systems (Cooper et al, 2003; 
Feldman et al, 1997).  The mGluR family is divided into 3 groups and contains a total of 
7 receptors subclasses.  Only the mGluR1 and mGluR5 receptor subclasses, which belong 
to Group I, have excitatory actions and are therefore the only mGluR receptors implicated 
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in the excitotoxic pathway.  These receptors are found on postsynaptic membranes and 
are Gq protein coupled.   
The mGluR(1,5) pathway is initiated when glutamate binding causes a 
conformational change that results in the release of the Gq alpha subunit.  As illustrated 
by Albert and others (2002), this alpha subunit phosphorylates nearby phospholipase C, 
which then cleaves membrane bound phosphatidylinositol 4,5-bisphosphate (PIP2) into 
two second messengers, inositol trisphosphate (IP3) and diacylglycerol (DAG).     As 
previously mentioned, the ER has IP3 gated Ca2+ channels on its membrane.  When 
bound, the channel opens to release Ca2+ filled vesicles into the cytoplasm.  DAG 
combines with Ca2+ to form a membrane bound DAG/ Ca2+ complex that is able to 
activate protein kinase C (PKC) (Albert et al, 2002).  PKC acts to phosphorylate proteins 
thereby changing membrane permeability to extracellular ions, including Ca2+.  In 
addition to increasing the intracellular Ca2+ load, DAG is also cleaved to form 
arachidonic acid (AA).  AA can change membrane permeability, effect ion pumps, and 
activate protein kinases.  The cleavage of AA initiates the inflammation pathway, 
producing eiconsinoids such as prostaglandin and leukotrienes, which can also lead to 
cell death (Marcoux & Choi, 2002).   
There are three ionotropic EAA receptors, N-methyl-D-aspartate (NMDA), α–
amino-3hydroxy-5-methyl-4isoxazoleproponic acid (AMPA), and kainic acid (KA) 
receptors (Mody, 1995); all three participate in producing glutamate mediated 
excitotoxicity (Marcoux & Choi, 2002).  The receptors have three transmembrane 
domains with the N terminus located extracellularly and an intracellular C terminus.  All 
receptors have been named for and can be pharmacologically distinguished by their 
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preferred agonist.  In fact, the receptors belonging to the AMPA and KA families are 
difficult to distinguish from one another outside of pharmacological discrimination; this 
is largely due to a high amount of heterogeneity within the two.  Such is the case that 
they are often referred to jointly as non-NMDA receptors.  Both of these non-NMDA 
receptors are voltage-independent, ligand-gated ion channels that mediate fast excitatory 
synaptic transmission (Cooper et al, 2003; Feldman et al, 1997).  When activated they 
allow for the influx of extracellular Na+.  In addition, activation of these receptors 
initiates a localized depolarization of the cellular membrane, a fact that is of functional 
importance to NMDA receptor activity.  The NMDA receptor is channel bound by 
magnesium (Mg+) ions.  This block is released upon membrane depolarization, which 
physiologically follows AMPA receptor activation (Koch et al, 2004).   Once the receptor 
channel is unblocked and in the presence of glycine and glutamate, the ion pore allows 
Ca2+ and Na+ to enter the cell, the latter in lesser amounts, as well as a minor efflux of 
potassium (K+) (Cooper et al, 2003; Feldman et al, 1997). 
The ionotropic EAA receptor mediated excitotoxic pathway has been 
characterized as being composed of two components, swelling followed by cell 
degeneration (Crews & Chandler, 1993; Olney, 1986).  In this model the stages are 
separated dependent upon time and ion involvement.  Minutes after an initial glutamate 
insult, excessive glutamatergic activation of AMPAR and KAR is believed to allow for 
the influx of excessive amounts of Na+ followed by a passive influx of Cl- and water, all 
combining to account for an increase in cellular volume (Maulucci-Gedde & Choi 1987).  
However, this acute swelling is not always sufficient to produce cell death (Albensi 2007; 
Choi 1992).  In fact, death is often not observed until a period of hours following 
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excitotoxic triggers, if at all.  The movement of Ca2+ via NMDA receptor activation has 
been implicated as the crucial component in the ultimate demise seen in association with 
glutamate induced excitotoxic cell death.   
 
Formation and Composition of the NMDA Receptor 
As previously mentioned, the NMDA receptor is both ligand gated and voltage-
dependent.  This dual activation is dependent upon both pre- and post-synaptic activity.  
The voltage sensitive Mg+ block is removed by local depolarizations that occur in the 
post-synaptic membrane, the ligand is provided by pre-synaptic release of glutamate.  
Due to these unique properties, the NMDA receptor is referred to as a “coincidence 
detector” (Köhr, 2006).  It is this ability of the receptor that allows it to produce long 
term potentiation (LTP) (Dong, 2009).   The receptor is also unique among the glutamate 
receptors in that, in humans, it requires two of its known subunits, the NR1 and NR2, in 
its channel structure to be functional (McIlhinney et. al., 2003).   A third and less 
frequently expressed subunit type, the NR3, is believed to form a tretrameric 
NR1/NR2/NR3 complex (Paoletti & Neyton, 2007).  All NMDA receptors require the co-
agonists glycine and glutamate to be bound at the NR1 and NR2 receptor subunits, 
respectively, for maximal activation.  If dual binding occurs during a localized 
depolarizing event, ion permeability changes and the channel pore will allow the entry of 
Ca2+and Na+, and small amounts of  K+ are allowed to exit the cell. 
The NR1 subunit is encoded by a single gene that can be spliced to form 7 
different variants.  The exact number of subunits required to produce a functional channel 
pore remains unclear, however, evidence supports either di-heteromeric (NR1/NR2A or 
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NR1/NR2B) or tri-heteromeric (NR1/NR2A/NR2B) structures (Al-Hallaq et al, 2007).  
Recent studies indicate that, in young rat hippocampi approximately two-thirds of NR2 
containing NMDA receptors are of the NR1/NR2A or NR1/NR2B structure while one 
third are NR1/NR2A/NR2B tri-heteromeric complexes (Al-Hallaq et al, 2007).  The 
NMDA receptor is complex, possessing many different recognition sites through which 
its function can be modified.  All NMDA receptors subunits contain large extracellular 
region that consist of two domains, the N-terminus domain and the agonist-binding 
domain (ABD), as well as an ion channel domain, which is contained within the cellular 
membranes (for review see Arundine & Tymianski, 2004; and also Paoletti & Neyton, 
2007).  Non-competitive antagonists including MK-801, mematine, and ketamine, as well 
as the endogenous Mg+ interact at the ion channel domain, the latter in a voltage-
dependent manner.  As previously mentioned, activation of NMDA receptors require the 
competitive co-gonists glycine (or D-serine) and glutamate.  Glycine binds at the ABD of 
NR1and NR3 subunits, while glutamate binds at NR2 subunit ABDs.   The N-terminus of 
the NR1 and NR2 subunits contain allosteric modulatory site for polyamines (Li et al, 
2007) this site is also used by the competitive antagonist ifenprodil (NR2B selective).  
The N-terminus of NR2 subunit also has an inhibitory site for endogenous Zn+ (NR2A 
and NR2B).    
 
Function and Regulation of the NR2B Receptor Subunit 
 The NMDA receptor is believed to be comprised of two obligatory NR1 subunits 
and two regulatory NR2 subunits.  The NR2 subunit has four variants (NR2A, -B, -C, and 
-D), which are encoded by four different genes (Dingledine et al., 1999).   The NR2A and 
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NR2B di-heteromeric complexes are the most common expressed in the CNS (Mony et. 
al., 2009; Yashiro & Philpot, 2008).  The prenatal and early postnatal rat brain contains a 
higher ratio of NR2B as compared to NR2A subunits.  However, with development, this 
ratio changes in both an activity-dependent and independent manner (for review see 
Yashiro & Philpot, 2008; Hardingham, 2009).  Activation of the NMDA receptor is 
associated with increased expression of NR2A mRNA.  Therefore, it is thought that when 
the NMDA receptor is active, NR2A subunits are expressed and become inserted at the 
synapse, changing the ratio of NR2B to NR2A subunits.  Additionally, NR2B subunit 
expression has also been shown to down regulate with development in an activity-
independent manner (Hardingham, 2009).    
The subunit composition of the NMDA receptor has direct implications toward its 
channel kinetics (Erreger et al., 2005; Vicini et al., 1998), synaptic localization (Köhr, 
2006), and protein binding partners (Hardingham et. al., 2002; Vanhoutte & Bading, 
2003; Ivonov et al., 2006).  Using recombinant NMDA receptors, Erreger and others 
have shown that NR1/NR2A heteromers had faster gating (open/close) time than did 
NR1/NR2B.  However, NR1/NR2B heteromers had longer activation duration, therefore 
greater total conductance of Ca2+.  Although subunit composition is important to the 
function of the NMDA receptor, another factor is the receptor location. NR2B containing 
NMDA receptors are found in higher concentration in the extrasynaptic space than are 
NR2A heteromers (for review see Köhr, 2006).  It appears that both location and subunit 
composition together indicate the intracellular signaling pathways that are activated by 
the NMDA receptor.  Several studies have suggested an opposing role for synaptic versus 
extrasynaptic NMDA receptor activation.  Synaptically located NR1A containing NMDA 
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receptors have been shown to activate cAMP response element binding protein (CREB; 
Hardingham et al., 2002) and, via CREB activation, brain-derived neurotrophic factor 
(BDNF) gene expression (Vanhoutte & Bading 2003), as well as extracellular signal-
regulated kinases (ERK; Ivanov et al., 2009).  In contrast, activation of the extrasynaptic 
NR2B subunit appears to shut off CREB activation and thereby decrease the expression 
of BDNF.  Similarly, activation of extrasynaptic NR2B containing NMDA receptors 
triggers the inactivation of ERK activity.  Lastly, using the Xenopus oocyte as an 
expression system, Williams (1994) found that the NR2B containing NMDA receptor is 
stimulatory when both active and bound by the polyamine spermine, a characteristic not 
found in the NR2A heteromer. 
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Chapter Two: The Role of Excitotoxicity in Disease 
 
Excitotoxicity and EtOH 
The affects of EtOH on the glutamatergic system are complex and still being 
defined.  It is believed that EtOH acts as an allosteric modulator at NMDA receptors.  
Acutely, EtOH acts to inhibit NMDA receptor activity; however, chronic EtOH exposure 
enhances activity at the receptor (for review see Kumari and Ticku, 2000).  In response to 
acute inhibition to EtOH, the cell is believed to upregulate NMDA receptors in order to 
maintain homeostatic intracellular Ca+ levels.  When EtOH, and therefore inhibition, is 
removed during withdrawal, the increased abundance of NMDA receptors can be 
activated to increase intracellular Ca+ to cytotoxic levels.  As previously discussed, 
NR2B containing NMDA receptors have a greater capacity for Ca2+ conductance than 
other NMDA receptor subunit compositions.  In addition to this, the polyamine binding 
site on the N-terminus of the NR2B that can potentiate NMDA receptor activity; EtOH 
exposure increases the amount of polyamines present in the brain.  Therefore, increased 
polyamines occurring in the presence of NR2B subunits can additively contribute to rises 
in intracellular Ca2+.  Finally, data indicate extrasynaptically located NR2B subunits can 
oppose some neurotrophic effects generated by cells in response to injury.                                
  
Excitotoxicity and Epileptic Seizures 
Epilepsy is a diverse brain disorder that has been classified into over 40 distinct 
types based on several different factors including age of onset, characteristic symptoms 
and signs, seizure types, cause, and electroencephalographic pattern (for review see 
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McNamara, 1999).  Genetics play an important role in epilepsy, with more than a dozen 
gene mutations identified as being linked to epileptic phenotypes.   
In 1983, Olney and colleagues replicated both status epilepticus and epileptic 
seizure activity by electrically stimulating the perforant pathway of the hippocampus, the 
structures major route for receiving information, for either 2 hours continuously or 
intermittently over a 24 hour period.  The group found neuronal degeneration, both 
somatic and dendritic, in the pyramidal cells of the CA3 and CA1 as well as evidence of 
neuron induced glial damage in the same areas.  These changes were attributed to over 
activation of the glutamatergic neurons of the hippocampus, which produced 
excitotoxicity.  Over activation of NMDA receptors during seizure activity can lead to the 
activation of proteases, damage to DNA, the creation of mPTP and subsequent activation 
of apoptotic cascades, all which can lead to cell death (reviewed by Fujikawa, 2005).   
 
Excitotoxicity and Traumatic Brian Injury  
Traumatic brain injury (TBI) can be classified into two categories (1) primary, 
which occurs at the time of injury and includes lacerations, fractures of the skull, 
hemorrhage, and surface contusions of the brain and (2) secondary, which can be initiated 
at the moment of injury but which develops over a subsequent period of time (Cater et al, 
2007; Graham et al, 2000).  Secondary injuries include edema, infection, ischemic 
insults, oxidative stress, and changes in endogenous neurotransmitters, including 
glutamate (Yi, et al., 2006).  As previously stated, glutamate is the most abundant 
neurotransmitter in the human CNS.  As would stand to reason, there are also an 
abundance of glutamatergic neurons in the CNS, as well as astrocytes, which transport 
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and breakdown glutamate.  When these neurons and astrocytes become damaged during 
either primary or secondary insult presented by TBI, their contents, including glutamate, 
can spill into the extracellular milieu.  The rise in glutamate activity can further 
exacerbate the TBI by producing and excitotoxic environment.   Therapeutics are directed 
at mediating these secondary effects includes targeting those mechanisms common to 
NMDA mediated excitotoxicity. 
   
Excitotoxicity and Hypoxia-Ischemia 
Hypoxic-ischemic (HI) conditions, when the brain is deprived of oxygen and 
glucose, can result in extracellular glutamate concentrations that deviate from 
homeostatic levels due in part to the rupture of glutamatergic neurons.  When these 
neurons rupture, the neurtotransmitters they contain, including glutamate, are spilled into 
the extracellular milieu, where they are free to affect neighboring neurons (Hardingham 
& Bading, 2003).  Also a factor in HI damage is the injury sustained by astrocytes, which 
normally function to remove glutamate from the synaptic space, thus allowing prolonged 
post synaptic stimulation (Hertz, 2008).  The NR2B NMDA receptor subunit, in 
particular, has been implicated in contributing to elevated intracellular Ca2+.  Reasons for 
this may due to the activation by the NR2B containing NMDA receptor complex by 
polyamines, which are expressed following brain injury (Li et al, 2007).  However, the 
rise in intracellular Ca2+ cannot solely be contributed to increased extracellular glutamate 
levels.  This was elucidated by Mitani (1993) in experiments using hippocampal slices 
from gerbils exposed to ischemic-like conditions (exposure to medium absent of glucose 
and oxygen).  The hippocampal tissue showed a significant rise in intracellular Ca2+ 
levels both in the presence and absence of media containing glutamate.  This intracellular 
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release of Ca2+ is thought to be attributed to activation of ER receptors, which release 
Ca2+ stores from the ER and to the dysregulation of mitochondria.  Mitochondrial 
dysregulation can lead to increased use but decreased production of ATP, which can 
break down the mitochondrial membrane, thereby releasing Ca2+ stores.  Rises in 
cytosolic Ca2+ via ER and mitochondria release can further cause the formation of mPTP 
and subsequent release of cyt c,  as well as activation of AIF, all culminating in 
excitotoxic cell death (for review see Arundine &Tianski, 2004).   
 
Excitotoxicity and Alzheimer’s Disease 
 The first indications that implicated the glutamatergic system in Alzheimer’s 
disease (AD) were proposed by Greenamyre et al. in 1988.  Upon autopsy of individuals 
who had died with AD, the group found a decrease in available glutamate binding sites 
that resulted in reduced glutamate binding in the cortical regions of the brain as compared 
to individuals who had no neurological disease.  Based upon these and other similar 
findings, the glutamatergic hypothesis of dementia was proposed (Albensi et al, 2004).  
Molecular hallmarks of AD include extracellular β-amyloid peptide (Aβ) plaque deposits 
and intracellular neurofibrillary tangles (NFT) in the hippocampus and other brain 
regions necessary to cognitive and memory function (as reviewed by Dong et al, 2009).  
It is suspected that Aβ plaques either sensitize or activate NMDA receptors (Koch et al, 
2004) and lead to widespread apoptosis in the pyramidal cells of the CA1 (Miguel-
Hidalgo et al, 2002).  The alteration of NMDA receptors allow their activation at μM 
concentrations of glutamate as opposed to the mM concentrations required under 
physiological conditions, producing excitotoxicity (Dong et al, 2009).  In the 
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hippocampus, neuropathic activity of NMDA receptors leads to memory and cognitive 
deficits because constant activation prevents the receptors from being “co-incidence 
detectors”, thus preventing LTP (Dong et al, 2009).  Further evidence implicating the 
NMDA receptor in AD is the action of the therapeutic drug memantine.  Memantine is 
low affinity blocker of the NMDA channel and works to “re-regulate” NMDA receptors 
that have been sensitized by Aβ plaques (Koch et al, 2004).  The goals of therapeutic 
drugs that target NMDA receptors being developed to treat AD such as memantine, are to 
prevent excitotoxicity and the downstream intracellular cascades that lead to 
mitochondrial dysfunction, caspase activation, and cell death.   
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Chapter 3: Summary and Hypothesis 
 
Summary 
Because Ca2+ has the ability to activate many different cell signaling pathways, 
regulation of this cation is crucial to cell survival and proper neuronal function.  
Excessive glutamatergic activity can bring about the disruption of Ca2+ homeostasis; this 
disruption can lead to excitotoxicity, a condition that can be fatal to cells.  Each EAA 
receptor represents a different pathway through which cytosolic Ca2+ levels can become 
elevated, thereby increasing the possibility of cell death.  However, the NMDA receptor 
is unique in its ability to produce excitotoxicity.   Because it contains a dense population 
of NMDA receptors and is therefore exquisitely susceptible excitotoxicity, the 
hippocampus is an ideal structure in which to study the phenomenon.  This brain 
structure is composed of three subregions, the granule cells of the DG and the pyramidal 
cells of the CA1 and CA3, of these, the CA1 has been shown most susceptible to 
excitotoxicity (Butler et al., 2009).  It has been suggested that this regional difference can 
be attributed to the larger population of mature neurons and dendritic processes found in 
the CA1.  In addition, the pyramidal cells of this subregion contain more NR1/NR2B 
heteromers than are found in other subregions, a configuration that confers greater 
conductance of Ca2+ across the membrane and a characteristic that is potentiated in the 
presence of polyamines.    
The proposed studies will examine the time-dependence of neuronal nuclear 
degradation (ie. PI fluorescence, NeuN staining) and loss of NR2B subunit density, 
following an excitotoxic insult to provide a better understanding of the topographical 
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nature of neuronal death following NMDA receptor activation.  The topographical 
"mapping" of neuronal injury or death following NMDA receptor activation is important 
as it may elucidate the specific cellular mechanisms that precipitate cellular demise.  
Identification of these mechanisms is crucial to the development of novel therapeutic 
strategies to be used in the treatment of disease states that are associated with excitotoxic 
insult.   
Hypotheses 
Experiment (1) NMDA, a NMDA receptor agonist, will be administered to 
hippocampal slices in levels sufficient to produce excitotoxicity; a NMDA receptor 
antagonist will be co-administered to an experimental group to as a proof of NMDA 
receptor mediated cell death.  After 24, 72, or 120 hours, granule cells of the DG and the 
pyramidal cells of the CA1 and CA3 regions of the hippocampal formation will be 
measured to assess cell death (i.e. propidium iodide (PI) fluorescence).  Experiment (2) 
following NMDA administration, immunohistochemical techniques will be used to assess 
loss of mature neurons (i.e. NeuN staining) over 24, 72, or 120 hour periods.  Experiment 
(3) procedures used in experiment 2 will be replicated using NR2B staining antibodies to 
assess loss of this subunit over the same time course.  It is hypothesized that, in reaction 
to NMDA: (1) cell death will be region dependent, with highest total loss occurring in the 
pyramidal cells of the CA1 hippocampal subregion (2) this cell death will be time 
dependent with the greatest cellular loss occurring after 24 hours (3) the total loss of 
mature neurons (NeuN staining) will be most substantial in the pyramidal cells of the 
CA1 hippocampal region (4) this loss of mature neurons will be significant after 24 hours 
and greatest after 120 hours (5) the total loss of NR2B subunits will be highest in the 
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pyramidal cells of the CA1 hippocampal region (6) this loss of NR2B subunits will be 
significant after 24 hours and greatest after 120 hours. 
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Chapter 4: Methods 
 
Organotypic Hippocampal Slice Culture Preparation 
Organotypic hippocampal slices will be obtained from 8-10 day old male and 
female Sprague Dawley rat pups (Harlan Laboratories, Indianapolis, IN, USA).  Pups will 
be decapitated; the whole brain extracted and placed in chilled dissecting medium 
comprised of Minimum Essential Medium containing Hanks’ salts and L-glutamine 
(MEM; Gibco, Gaithersburg, MD, USA), 25 mM HEPES (Sigma-Aldrich Co., St. Louis, 
MO, USA), and 50 µM Penicillin/Streptomycin (Gibco).  The bilateral hippocampi will 
be removed, placed in culture medium composed of dissecting medium with the addition 
of: 36 mM glucose (Fisher Scientific, USA), 25% (v/v) Hanks’ balanced salt solution 
(Gibco), 25% heat-inactivated horse serum (Sigma-Aldrich Co.), and 0.05% Penicillin/ 
Streptomycin.  Under a dissecting microscope, loose and extra tissue will be removed.   
Each hippocampus will be coronally sectioned into 200µm slices using the McIllwain 
Tissue Chopper  (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK), yielding 
approximately 12 slices (approximately 24 per animal), and placed into fresh culture 
medium.  Slices will be sorted under a dissecting microscope to remove damaged or 
partially sectioned specimens.  Using transfer pipettes, intact slices will be placed three 
per well onto porous Teflon membrane inserts (Millicell-CM 0.4 μm; Millipore, 
Marlborough, MA) that had been incubated in 1 ml of culture media for a period of at 
least one hour.  Excess culture media will be aspirated from the top of the membrane.  
Plates will be comprised of 6 wells and will yield 18 slices per plate.  After plating, slices 
will remain in an incubator exposed to an atmosphere of 5% carbon dioxide 95% air and 
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at constant temperature of 37⁰C for 5 days to allow the tissue to adhere to the membrane 
and to stabilize the slices.  This method was adapted from Stoppini et al., 1991.  Care of 
all animals will be performed in accordance with the guidelines of the National Institutes 
of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-
23), as well as with the University of Kentucky’s Institutional Animal Care and Use 
Committee.  All experiments discussed will be replicated using different rat litters.   
 
NMDA Stimulated Excitotoxicity 
Excitotoxicity will be induced in cell cultures using NMDA, a selective agonist of 
the NMDA receptor. NMDA will be chosen over glutamate, the endogenous NMDA 
receptor ligand, to isolate NMDA receptor activation from other EAA receptors.  DL-2-
Amino-5-phosphonopentanoic acid (APV), a selective NMDA receptor antagonist, will 
be used to block the activation of the NMDA receptor. After 5 days in vitro (DIV), inserts 
will be transferred into plates filled with 1 ml of fresh, pre-incubated media that will 
contain 3.74 μM propidium iodide (PI) (Sigma-Aldrich) and, in addition, will contain 
either 50 μM APV (Sigma-Aldrich), 20μM NMDA (Sigma-Aldrich), or 20 μM NMDA 
and 50 μM APV (NMDA/APV).  Cultures will be returned to the incubator and allowed 
to rest for a period of 24, 72, or 120 hours.  After each of these time points, plates will be 
removed from the incubator and assessed for cell cytotoxicity as described below.    
 
Propidium Iodide Uptake in Treated Cultures 
Fluorescent microscopy of propidium iodide (PI) will be used to assess levels of 
cell cytotoxicity incurred by cell cultures after time dependent exposure to NMDA and/or 
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APV. Membrane impermeable PI binds to DNA and RNA once the cellular membrane 
becomes compromised.  Once bound to these nucleic acids, the fluorescence of PI is 
enhanced 20-30 fold (Arndt-Jovin & Jovin, 1989).  This altered wavelength allows for 
non-bound concentrations of PI to be excluded from analysis.   The use of this staining 
technique has been significantly and reliably correlated with other measures of cell death 
and cytotoxicity (for review, see Zimmer et al., 2000).  Uptake of PI will be imaged with 
SPOT Advanced version 4.0.2 software for Windows (W. Nuhsbaum Inc., McHenry,IL) 
using a 5x objective on a Leica DMIRB microscope (W. Nuhsbaum IL) fitted for 
fluorescence detection (mercury-arc lamp) and connected to a personal computer via a 
SPOT 7.2 color mosaic camera (W. Nuhsbaum Inc.).  When bound to nucleic acids, the 
peak excitation wavelength of PI is 535 nm, with emission maximum of 617nm.  The 
wavelength will be excited to between 510-560 nm using a rhodamine band-pass filter.  
The intensity of PI within each culture will be determined by densitometry using Image J 
1.29x (National Institutes of Health, Bethesda, MD).  Three cell layer regions of the 
hippocampal formation were analyzed for cytotoxicity, the granule cells of the dentate 
gyrus (DG) and the pyramidal cells of the cornu Ammonis-3 (CA3) and cornu Ammonis-
1 (CA1).  The visual field containing each sub-region of interest will be measured; a 
background measure will be also taken for each tissue slice analyzed.  To reduce 
environmental variations between slices, the background value will be subtracted from 
each sub-region value.  This will result in an intensity measure for each sub-region of 
each slice, 9 measures per well, 54 per plate.  These values will be recalculated, dividing 
by intensity values for a control plate, to express the value as a percent of control. 
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 Immunoreactivity of Neuron Specific Nuclear Protein and NMDA NR2B Subunits 
Immunohistochemical labeling using monoclonal antibodies will be used to 
measure the density of both mature neurons and NMDA NR2B subunits.  Neuron specific 
nuclear protein (NeuN) primary antibody will be used to identify mature neurons in the 
granule cells of the DG and the pyramidal cells of the CA1 and CA3 of the hippocampus. 
NeuN antibody recognizes the neuron-specific NeuN protein, which is found in the CNS 
of all vertebrates (Mullen, 1992).  NeuN is first evident in neurons shortly after they 
become post-mitotic and/or shortly after differentiation (Mullen, 1992).  Therefore, 
strong staining of NeuN indicates the presence of mature cells.  The monoclonal anti-
NR2B primary antibody will be used to measure the density of NMDA NR2B subunits in 
the same hippocampal regions.  Mouse or rabbit fluorescein isothiocyanate (FITC)-
conjugated secondary antibody will be used with NeuN and NR2B antibodies, 
respectively.    
Following PI analysis discussed previously, culture slices will be removed from 
culture medium for fixation with 10% formalin, during this procedure slices will be 
preserved on previously plated inserts.  Inserts will be immersed in wells containing 1 ml 
of formalin, an additional 1 ml of formalin will be applied to the top of the insert; inserts 
will be allowed to rest in formalin for 30 minutes.  Inserts will be removed from formalin 
plate and will be placed in plates containing 1ml of 1x PBS, with 1 ml 1x PBS slowly 
added to the top of the insert, then drained, a procedure termed washing.  This wash will 
be performed twice before inserts will be transferred to plates containing 1 ml of 1x PBS 
and stored at 4°C until immunohistochemistry will be conducted.  Prior to 
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immunohistochemistry, slices will be placed in a plate containing 1ml buffer consisting 
of 1x PBS, 0.005% bovine serum albumin, and 0.1% Triton-X (Sigma-Aldrich), with 1 
ml of buffer slowly added to the top of insert.  Cultures will be allowed to rest for 45 
minutes to permeabilize cell membranes.  Following this incubation period, cultures will 
be transferred into fresh plates containing 1 ml of1 x PBS, 1 ml of buffer and mouse anti-
NeuN monoclonal primary antibody (1:200; Chemicon, Temecula, CA) or rabbit anti-
NR2B monoclonal primary antibody (1:500; Chemicon, Temecula, CA) will be added 
slowly to top of inserts; cultures will be stored for 24 hrs at 4°C. Following this 
incubation period, cultures will be washed twice in 1x PBS and placed into fresh culture 
plates containing 1 ml of 1 x PBS, 1 ml of buffer and anti-mouse (NeuN; 1:200) or anti-
rabbit (NR2B; 1:200) fluorescein isothiocyanate (FITC)-conjugated secondary antibody 
(Sigma-Aldrich) will be slowly added to top of inserts previously treated with NeuN, 
those previously treated with NR2B will receive the same treatment but with anti-rabbit 
FITC (1:200; Sigma-Aldrich). Plates will be stored at 4°C for 24 hours before fluorescent 
images will be taken.  FITC fluorescence will be elicited using a band-pass filter that 
excites wavelengths of approximately 495 nm (emission wavelength = 520 nm). Images 
will be taken using a 5× objective lens, as described previously.   
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Chapter 5: Results 
 Statistical Analysis 
Two-way ANOVA (treatment x region) was conducted to investigate the validity 
of the a priori hypothesis regarding regional differences in reaction to exposure to 
NMDA.  Three-way ANOVA (time x treatment x sex) was conducted to investigate 
differences within the subregions of the hippocampus.  A reduced design, two-way 
ANOVA (treatment x time), was used if no effect of sex was detected by the omnibus 
analysis.  Following ANOVA analyses, the Fisher’s LSD post-hoc test was interpreted 
when appropriate; significance level was set at P < 0.05.    All analyses are of a between 
subjects design and all data is expressed as percent control for ease of interpretation.  
Experiments were replicated a minimum of two times, all data represent tissue sampled 
from a minimum of two litters.  Tissue from both male and female animals was used.    
 
Results 
Propidium Iodide Uptake in Treated Cultures 
Densitometric analysis of cell toxicity as measured by PI fluorescence was 
evaluated in the pyramidal cell layers of the CA1 and CA3 and the granule cell layer of 
the DG.  To test the a priori hypothesis that exposure to 20 μM NMDA would  produce 
greater toxicity in the CA1 as compared to the CA3 and DG, a two-way ANOVA 
(treatment x region) was performed.  A significant interaction was found (F(6, 
1262)=25.508; P<0.001).  As predicted, increased PI fluorescence was largest in the CA1 
(277.545, ±14.489) as compared to the CA3 (211.001, ±17.37) and the DG (132.505, ± 
5.759; Fig. 1).  Further analysis was conducted to explore differences within the 
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subregions of the hippocampus.  A three-way ANOVA (time x treatment x sex) was 
conducted in each region (CA1, CA3, DG), which revealed no significant sex effect in 
any region.  A reduced, two-way ANOVA (treatment x time), revealed a significant 
interaction within the CA1 (F(6,420)= 16.728, P < 0.001).   NMDA treatment resulted in 
significant toxicity on days one (319.41, ±32.38), three (338.34, ±14.63), and five 
(173.62, ±12.63; Figure 2A) as compared to controls.  These data are consistent with the 
previously stated hypothesis, which predicted the greatest toxicity would occur on day 
one.  As compared to control values, NMDA/APV was not associated with significant 
increases in PI fluorescence on days three and five but did reach significance on day one 
(138.78, ±8.28; Fig. 2A).  However, co-administration of NMDA/APV did reduce 
NMDA induced damage at all time points.  APV exposure resulted in no significant 
change in PI fluorescence as compared to controls at any time point (Table 1).    In the 
CA3, two-way ANOVA (treatment x time) revealed a significant interaction (F(6,420) = 
19.345, P < 0.001).  APV and NMDA/APV treatment groups did not differ significantly 
from control values at any time point (Table 1, Fig. 1B).   However, NMDA treatment 
produced significant toxicity as compared to controls, reaching maximal effect on day 
one (345.77, ±42.29), which diminished on day three (135.38, ±6.90), from which there 
was no significant change on day five (148.01, ±6.84, P<0.508); Figure 1B).  Within the 
DG, two-way ANOVA (treatment x time) revealed no significant interaction (Figure 1C).  
However, a main effect for treatment (F(3, 420)=15.956, P<0.001) was found, with 
NMDA (132.33, ±3.423) and NMDA/APV (113.512, ±3.439) treatments associated with 
significantly higher PI fluorescence as compared to control values.  However, APV co-
administration was effective at reducing NMDA induced damage.  
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Figure 1: Effects of exposure to 20µM NMDA on PI fluorescence in the pyramidal cells 
of the CA1 as compared to the pyramidal cells of the CA3 and the granule cells of the 
DG (* p< .05 vs. CA1). 
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Figure 2A-C: Time dependent effects of exposure to 20µM NMDA or 20µM NMDA + 
50µM APV on PI fluorescence in the pyramidal cells of the CA1 (A), CA3(B), and the 
granule cells of the DG (C). (* p< .05 vs. control; ** p< .05 vs. Day 1; # main effect of 
treatment p<.05). 
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Immunoreactivity of Neuron Specific Nuclear Protein 
Mature neuron density, as indicated by NeuN immunoreactivity, was analyzed using 
densitometry for the pyramidal cell layers of the CA3 and CA1 and the granule cell layer 
of the DG.  To test the a priori hypothesis that exposure to 20 μM NMDA would produce 
greater reductions in the density of mature neurons in the CA1 as compared to the CA3 
and DG, a two-way ANOVA (treatment x region) was performed, a significant 
interaction was found (F(6, 2075)=14.807; P<0.001).  As predicted, reduction in NeuN 
reactivity was largest in the CA1 (52.57, ±1.42) as compared to the CA3 (76.36, ±1.80) 
and DG (76.37, ±1.37).   No significant difference was found between the latter two 
regions (Fig. 3).  Further analysis was conducted to explore differences within the 
subregions of the hippocampus.  A three-way ANOVA (time x treatment x sex) was 
conducted in each region (CA1, CA3, DG), which revealed no significant sex effect.  A 
reduced design, two-way ANOVA (treatment x time), revealed a significant interaction 
within the CA1 (F(6, 691)= 6.13, P<0.001).  In this region, NMDA treatment was shown 
to significantly reduce the density of mature neurons relative to controls at all time 
points.  Supporting the hypothesis regarding time-dependent loss in this region, 
significant declines in the density of mature neurons was observed at day one (62.04, 
±2.67).  Contrary to the hypothesis, which stated that the largest decline would be evident 
at day five, there was a decline at day three (47.82, ±2.84), from which there was no 
significant change on day five (47.95, ±2.58; Fig. 3A).    NMDA/APV treatment group 
values were significantly different from control values, with an increase in NeuN 
immunofluorescence at day five (116.65, ±4.68; Fig. 3A), illustrating that APV blocked 
NMDA mediated reduction in mature neurons.  No significant effect was associated with 
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APV treatment in the CA1 at any time point (Table 2).  Two-way ANOVA (treatment x 
time) in the CA3 revealed no significant interaction, however, there was a main effect of 
treatment (F(3, 691)=46.451, P<0.001).  Significant treatment effects were seen upon 
exposure to NMDA (76.252, ±1.884) and APV (108.83, ±2.93; Fig. 3B; Table 2).   Two-
way ANOVA (treatment x time) in the DG also revealed no significant interaction.  
However, there was a main effect of time (F(2,691)=7.44, P<0.001) and treatment 
(F(3,691)=56.625, P<0.001).  NMDA treatment (73.346 ±1.423) produced significantly 
lower NeuN immunofluorescence as compared to control group in this region (Fig. 3C). 
Imunoreactivity of NMDAR2B Subunits  
Density of NMDAR2B subunits, as indicated by NR2B immunoreactivity, was analyzed 
using densitometry in the pyramidal cell layers of the CA1 and CA3 and the granule cell 
layer of the DG.  The a priori hypothesis, which stated that exposure to 20 μM NMDA 
would result in a 
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Figure 3: Effects of exposure to 20µM NMDA on NeuN immunofluorescence in the 
pyramidal cells of the CA1 as compared to the pyramidal cells of the CA3 and the 
granule cells of the DG (* p< .05 vs. CA1). 
33 
 
CA1
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
0
20
40
60
80
100
120
140A
CB CA3
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
N
eu
N
 Im
m
un
or
ea
ct
iv
ity
%
 C
on
tro
l
0
20
40
60
80
100
120
140
*
*
*
*
DG
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
NM
DA
NM
DA
 + 
AP
V
0
20
40
60
80
100
120
140
20  µM NMDA
50  µM APV
1 Day 3 Day 5 Day
1 Day 3 Day 5 Day
1 Day 3 Day 5 Day
N
eu
N
 Im
m
un
or
ea
ct
iv
ity
%
 C
on
tro
l
****
# #
#
# ##
+
 
Figure 4A-C: Time dependent effects of exposure to 20µM NMDA or 20µM NMDA + 
50µM APV on NeuN protein immunofluorescence in the pyramidal cells of the CA1 (A), 
CA3(B), and the granule cells of the DG (C). ( * p< .05 vs. control; ** p< .05 vs. Day 1, 
# main effect of treatment p<.05, + main effect of time p<.05). 
 
 
greater reduction of NR2B subunit protein in the CA1 as compared to the CA3 and DG, 
was tested by conducting a two-way ANOVA (treatment x region).  A significant 
interaction was found (F(6, 2183)=8.881, P,0.001), with a greater loss of NR2B protein 
occurring in response to NMDA exposure in the CA1 (83.699, ± 1.106) as compared to 
CA3 (93.665, ± 1.106) or DG (92.816, ±  1.106; Fig. 5), consistent with the hypothesis.  
Analysis exploring differences within the subregions of the hippocampus was initially 
conducted using a three-way ANOVA (time x treatment x sex), for each region.  No 
significant sex effect was found in any region, therefore, a reduced design, two-way 
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ANOVA (time x treatment), was used for subsequent analysis.  Within the CA1, two-way 
ANOVA (treatment x time) revealed a significant interaction (F(6, 727)= 11.24, 
P<0.001).  NMDA treatment significantly reduced NR2B density on days three (73.885, 
± 1.840) and five (77.184, ±1.861; Fig. 6A).  NMDA/APV treated group did not differ 
significantly from control group any time point (Fig. 6A), verifying that APV was 
effective in this area of mediating NMDA induced loss of NR2B subunits.  APV 
treatment significantly altered NR2B subunit density on day one (112.38, ±2.86) and day 
five (90.96, ±2.93; Table 3).  Two-way ANOVA (treatment x time) revealed a significant 
interaction within the CA3 hippocampal region (F(6,727)=7.18, P<0.001).  NMDA 
treatment significantly changed NR2B subunit density on days one (105.48, ± 1.792), 
three (88.90, ±1.812), and five (86.17, ±1.834; Fig. 6B).  Treatment with NMDA/APV 
was shown to significantly reduce NR2B subunit density on day three (90.96, ±2.817; 
Fig. 6B).  APV resulted in altered subunit levels on days three (89.01, ±2.27) and five 
(89.01, ±2.76; Table 3).  Two-way ANOVA (treatment x time) conducted in the DG 
revealed a significant interaction (F(6, 727)=5,820, P<0.001).  NMDA exposure was 
shown to reduce NR2B subunit protein on day three (84.995, ±1.725) and day five 
(89.866, ±1.745).  Additionally, exposure to NMDA/APV significantly reduced NR2B 
subunit protein on day three (88.773, ± 2.681).  Treatment with APV was associated with 
decreased NR2B immunoreactivity on day three (89.01, ± 2.72) and day five (89.01, ± 
2.76).     
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Figure 5: Effects of exposure to 20µM NMDA or 20µM NMDA + 50µM APV on NR2B 
protein immunofluorescence in the pyramidal cells of the CA1 (A), CA3(B), and the 
granule cells of the DG (C)  ( * p< .05 vs. CA1). 
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Figure 6 A-C: Effects of exposure to 20µM NMDA on NR2B immunofluorescence in the 
pyramidal cells of the CA1 as compared to the pyramidal cells of the CA3 and the 
granule cells of the DG on day1(A), day 2 (B), and day 3 (C) ( * p< .05 vs. CA1;**p<.05 
vs. Day 1). 
 
36 
 
Table 1: PI uptake in response to 50 μM APV treatment.  Values expressed as percent control. 
 (p< .05 vs. control, # indicates main effect of treatment) 
Treatment Period 
1 Day 3 Days 5 Days
Subregion         
CA1  100.06 ± 5.06 98.78 ± 2.90 122.3 ± 4.92
CA3  98.03 ± 4.11# 101.47 ± 4.77# 109.28 ± 4.05#
DG  106.5 ± 3.65 109.06 ± 6.10 108.7 ± 4.11
 
 
Table 2:  NeuN immunoreactivity in response to 50 μM APV treatment.  Values expressed as 
percent control. (* p< .05 vs. control) 
Treatment Period 
1 Day 3 Days 5 Days
Subregion         
CA1  102.45 ± 4.85 100.726 ±5.46 92.637 ± 5.31
CA3  108.81 ± 6.05 102.749 ± 6.46 114.93 ± 6.34
DG  108.86 ± 5.91 94.716 ± 4.45 99.69 ± 2.86
 
Table 3:  NMDA NR2B subunit immunoreactivity in response to 50 μM APV treatment.  Values 
expressed as percent control. (* p< .05 vs. control) 
Treatment Period 
1 Day 3 Days 5 Days
Subregion         
CA1  112.38 ± 2.41* 97.76 ± 2.55 90.96 ± 2.44*
CA3  102.91 ± 2.22 94.57 ± 2.21 83.55 ± 4.32*
DG  101.81 ±1.99 89.01 ± 2.47 * 89.01 ± 2.20*
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Chapter 6: Discussion  
Glutamate mediated activity is a crucial component in the proliferation, 
maintenance, and survival of neurons (Cooper et. al., 2003; Hardingham & Bading, 
2003).  This is due in part to its ability to provide much needed calcium Ca2+ to the 
intracellular environment.  At physiological levels, intracellular Ca2+ is vital to the 
phosphorylation and synthesis of proteins, cellular communication, and gene expression.  
However, overexposure to glutamate or exposure to excessive concentrations of the 
neurotransmitter, can allow intracellular Ca2+ to exceed physiological levels, a condition 
defined by Olney as excitotoxicity (Choi, 1992; Olney, 1986). Pathological intracellular 
Ca2+ concentrations can lead to the loss of cellular components via activation of multiple 
signaling pathways, proteases, lipases, as well as to the disruption of mitochondrial 
membrane potential, all of which can culminate in cell death (Albensi, 2007; Choi et. al., 
1987; Forder, 2009; Hardingham & Bading, 2003).  Due to its crucial role in cell viability 
there are several mechanisms in place dedicated to maintaining Ca2+ homeostasis.   These 
include the PMCA transporter and Na+/Ca2+ exchanger, which both work to remove Ca2+ 
from the cytosol (Choi, 1992; Dingledine et al., 1999).  Additionally, the Na+/Ca2+ 
exchanger works to reset resting membrane potential, thereby limiting activation of 
voltage dependent calcium channels and NMDA receptors (Choi, 1992; Dingledine et al., 
1999).  The family of glutamatergic receptors is also important to Ca2+ homeostasis 
(Cooper et al. 2003).  These receptors can change intracellular Ca2+ concentrations either 
directly, as with the previously mentioned NMDA receptor, or indirectly, as with the 
mGluR and AMPA/KA receptors. mGluRs are capable of disrupting Ca2+ homeostasis by 
activating IP3, an agonist capable of releasing intracellular stores of Ca2+.  Additionally, 
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because antagonizing these receptors dampens NMDA activity, the mGluRs are 
suspected to interact with the intracellular NMDA receptor domain to modulate activity 
(Harris, et al., 2002).  Activation of the NMDA receptor directly changes membrane 
permeability by opening a membrane channel pore, which allows the entry of Ca2+ as 
well as Na+ (Cooper et al. 2003).  Physiological activation of the NMDA receptor is 
integral to learning and the formation of memories.  However, pathological activation of 
this receptor is sufficient to bring about excitotoxicity; such is the case that its activation 
is dependent upon two events occurring simultaneously.  First, the receptor must be 
bound by both glycine and glutamate and, while bound, a localized membrane 
depolarization, which removes Mg+ from the receptor channel, must also occur.  
Depolarization of the membrane is carried out by glutamatergic AMPA/KA receptors and 
is opposed by GABA receptors; both are co-localized with NMDA receptors.  The 
receptors and exchangers discussed here are all crucial to maintaining Ca2+ homeostasis.  
However, once homeostasis is disrupted, they are also the means by which rises in 
cytosolic Ca2+ concentrations occur.  Due to its ability to contribute to an excitotoxic 
intracellular environment, the NMDA receptor has been the focus of numerous 
investigations, including the current research.   
Once NMDA receptors are activated, ionic membrane permeability is determined 
by the stoichiometry of the receptor, with NR2B containing NMDA receptors able to 
conduct the greatest concentrations of Ca2+ due to longer channel opening time (Erreger 
et al., 2005).  Additionally, the NR2B receptor is unique among the receptor subunit 
types in its excitatory reaction to polyamines.  Polyamines are expressed during 
excitotoxic events such as alcohol withdrawal and TBI (Williams, 1994).  This unique 
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consequence increases the ability of the NR2B subunit to confer Ca2+ across the 
membrane.  Further, recent evidence indicates that NR2B containing NMDA receptors 
that are located extrasynaptically may inhibit activation of protective mechanisms such as 
BDNF (Vanhouk & Badding, 2003), CREB (Hardingham et al., 2003), and ERK (Ivanov 
et al., 2009).  Therefore, activation of these receptors could worsen damage by inhibiting 
the cells naturally occurring repair mechanisms.  The pyramidal cells of the CA1 express 
a high density of NR2B subunits as compared to the CA3 and DG (Butler et al., 2010).  
Additionally, this subregion has a greater density of mature neurons and greater 
expression of NMDA receptors (Butler et al., 2010).  It is therefore not surprising that, as 
hypothesized, this subregion also incurred the greatest NMDA induced damage as 
compared to the CA3 and DG.  Importantly, the pyramidal cells of the CA1 project to 
cortical regions of the brain and are crucial to learning and the formation of memory.  It 
is therefore understandable that those neurodegenerative disorders associated with 
excitotoxicity are also associated with memory dysfunction.   
Given the central role of the NMDA receptor to the current research, it was 
important to demonstrate that the treatment effects observed could be attributed to 
activation of this receptor and not due to generalized activity.  This was achieved by co-
exposing cultures to APV and NMDA, which effectively reduced excitotoxicity to 
control values (as measured by PI and NeuN) at all time points investigated.  Therefore, it 
can be said that damage related to the NMDA treatment was mediated selectively by the 
NMDA receptor.  Previously stated hypotheses indicated that NMDA treatment would 
have significant effects on day one and greatest effects on day five (NeuN and NR2B).  
PI fluorescence was predicted to be greatest on day one and to decline by day five, as the 
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signal was degraded.  This occurrence would imply that, upon excitotoxic stimulation of 
the NMDA receptor, a mass damage was affected, which destroyed the cell soma, 
membrane, and dendrites all following a 24 hour time lapse and escalate uniformly until 
day five.  However, this did not occur. The greatest membrane damage (PI) was observed 
on day one, consistent with the hypothesis.  This loss was maintained through day three, 
and did not decline back to raw control values (data not shown) until day five.  Declines 
in the density of mature neurons were significant on day one and peaked on day three, 
which was not hypothesized.  It was the pattern of NR2B subunit protein loss that was 
quite different than expected.   Decreases in these protein levels did not vary from 
controls until day three and did not significantly vary on day five.  Together, these results 
imply that damage begins in the soma, where neuronal markers were affected by NMDA 
exposure first.  This damage then cascades to affect NR2B protein density in the distal 
projections of the neuron, the dendrites.  These effects are elucidated in the visual 
timeline provided in Figure 8.   
The most likely reason for NR2B protein loss can be explained by a 
compensatory down regulation and subsequent reabsorption of the subunit protein.  In 
response to excessive influxes of Ca2+, the cell would attempt to regain homeostasis by 
internalizing and reabsorbing the receptor proteins, thus limiting the influx of the cation.  
It is important to note that, because the cell membrane is permeabilized prior to 
immunohistochemistry, NR2B staining in these experiments represents both surface 
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 Figure 7: Visual timeline.  Representative images of control and 20µM NMDA exposed 
hippocampal slices during days one and five on NeuN immunofluorescence, PI 
fluorescence, and NR2B immunofluorescence.    
 
receptors as well as those that are intact but that have been internalized.  Therefore, 
reductions seen in the NR2B marker would represent a total loss of the protein.  Research 
conducted in cortical neurons by Bretin et al.(2002), found that transient exposure to 50 
μM concentration of NMDA led to decreases in NR2B surface receptors but not total 
receptor density.  To obtain a loss in total receptor density, 200 μM concentrations of 
NMDA were necessary.  Importantly, this receptor trafficking was mediated by the 
enzyme calpain, which is dependent upon increased levels of intracellular Ca2+ 
concentrations for activation.  Although the concentration of NMDA necessary to 
decrease NR2B proteins in the Bretin et al.(2006), data is 10 times that used in the current 
research, exposure time was measure in seconds, whereas tissue in the current research 
was exposed for days.  Therefore, it is feasible that lengthening exposure time would 
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produce increases in Ca2+ concentrations sufficient to activate calpain, leading to the 
down regulation and reabsorption of NR2B subunit proteins observed.  Calpain activation 
is most often associated with detrimental effects resulting from excitotoxicity due to is 
capacity to perpetuate increased intracellular Ca2+ concentrations by disrupting the 
mechanisms crucial in the maintenance of Ca2+ homeostasis.  For example, known 
substrates for calpain include the PMCA transporter and Na+/Ca2+ exchanger.  As 
discussed previously, these plasma membrane proteins work to transport Ca2+ from the 
cytosol.  Once activated, calpain is able to degrade these proteins, leaving the cell without 
a high or low affinity Ca2+ transporter (Magnusson et. al., 1993).  Additional substrates 
for calpain include, the IP3 and ryanodine receptors, both act to sequester Ca2+ in the ER; 
degradation of these receptors terminate their ability to function.  The protective and 
deleterious activity of calpain elucidates the complexity and diversity of enzymes and 
signaling molecules activated in response to excitotoxic insult.  Beneficially, however, 
this complexity offers several opportunities for intervention before cell death becomes 
inevitable.   
These data indicate the search for such opportunities to block cell death 
mechanisms should focus on the soma.  The ER and mitochondria, which are resident in 
the soma, are likely candidates for such research.  Under physiological conditions, the ER 
maintains high Ca2+ concentrations within its membrane and expresses two Ca2+ 
mediating receptors, the IP3 and ryanodine receptors.  The IP3 receptor is activated by 
IP3, which is bound intracellularly to the plasma membrane and is co-localized with 
mGluRs. When mGluRs are activated by extracellular glutamate, IP3 is released from the 
plasma membrane and is then free to migrate to the ER membrane.  There, it can bind to 
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and activate IP3 receptors, changing ER membrane permeability to Ca2+, which will give 
rise to cytosolic Ca2+  levels.  The ryanodine receptor, also located on the ER membrane, 
is activated by cytosolic Ca2+.  Therefore, increases in local cytosolic Ca2+ provided by 
activation of IP3 receptors can also provide the ligand for ryanodine receptor activation, 
leading to a further release of ER sequestered Ca2+.  These increased cytosolic levels of 
Ca2+ additively affect an already excitotoxic environment.  Similar to the ER, 
mitochondria also sequester cytosolic Ca2+.  This is done in response to elevated cytosolic 
Ca2+ concentrations.  However, during excitotoxic conditions when mitochondrial Ca2+ 
accumulation is prolonged, the mitochondria membrane becomes depolarized and mPTPs 
can form; conditions that will release Ca2+ stores and destroy the organelle.  In addition to 
releasing Ca2+ stores and further elevating cytosolic Ca2+ levels, compromise of the 
mitochondrial membrane can also lead to the release of membrane bound cytochrome c 
and AIF, both are initiators of apoptosis.  It is possible that, by blocking the IP3 receptor 
on the ER membrane, the Ca2+ mediated Ca2+ release that would normally follow could 
be prevented.  This could halt or slow the activation of death pathways, reducing overall 
neurodegeneration.        
It is important to note that, as these data have been presented thus far, they 
represent one of several possible interpretations.  Additionally, there has been no 
discussion of limitations concerning the methods employed during these experiments.   
As these aspects are important to all research, limitations and alternate interpretations 
regarding the current research project will follow.  
One limitation in methodology concerns the PI marker.  As explained previously, 
PI binds to nucleic acids.  However, upon excitotoxic insult, glia cells can become 
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damaged and can expose nucleic acids to which PI can bind.  The resulting PI signal is 
therefore increased from what would be evidenced from neuronal injury alone.  
Importantly, NeuN, the marker for mature neurons, is specific to neuronal cells.  Because 
both markers are represented and additionally, tell the same story regarding excitotoxic 
damage, the increased fluorescence provided by glial contents is not believed to 
significantly affect the data.  A second issue regarding the methods concerns the age of 
the animals used in this study.  Because the rats are PND 8, there are certain limitations 
concerning the translation of data.  It is important to understand that the organotypic 
hippocampal model is just that, a model.  By definition, models are representative and 
data derived from them should be translated with this fact in mind.  While it is likely that 
the mechanisms behind excitotoxicity are similar in early development and maturity, 
there are cellular molecules whose expression changes with age.  For example, calapain 1 
expression increases during develop in the rat CNS (Li, et al., 2009).  Because this 
enzyme is implicated in mediating events associated with excitotoxicity, knowledge of 
how its expression changes during development is important when interpreting and 
translating data to more developed systems.  
The method of organotypic hippocampal slice culture provides researchers many 
benefits including the ability to mirror in vivo circuitry.  However, an important 
limitation especially pertinent to the current research concerns this circuitry.  It has been 
shown that over time the CA1 subregion undergoes synaptic reorganization over time and 
will develop projections to the DG that are unique to in vitro cultures (Gutiérrez & 
Heinemann, 1999).  Therefore, the excitotoxicity seen in the CA1 is perhaps increased 
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from what would be seen in vivo, as these projections have the ability to confer increased 
excitability from the DG to the CA1.  
   Perhaps the most important caveat to interpreting this data set revolves around 
the NR2B subunit.  Throughout this document, it has been stated that NR2B subunit 
proteins are expressed in the dendrites of the pyramidal cells of the CA1.  While this is 
true there are also populations found in the membrane of the soma.  In the current 
interpretation, the decrease of NR2B subunits on day three is said to occur on dendritic 
processes.  However, it is possible that the declines are occurring in those receptors 
populating the soma or declines may be representative of the two locations.  However, 
because the data show that injury to the neuron begins 24 hours after exposure to NMDA 
and this initial injury is occurring in the soma, it is likely that the more distal dendrites 
would experience delayed degeneration seen on day three.  Additionally, because 
methods used in this study have measured only protein levels, no statement can be made 
regarding the functionality of the remaining receptor subunits.  To definitively identify 
what area is incurring the subunit proteins loss or to investigate the functionality of the 
remaining receptors will require subsequent investigation.  These studies could include 
staining the cells with MAP-2, which is a marker for proteins that make up the structure 
of membranes.  This marker would allow the topography of the entire neuron to be 
visualized using confocal microscopy.  By co-labeling with MAP-2 and NR2B, it would 
be evident where on the neuronal membrane loss of the subunit proteins was occurring.  
The functionality of the receptors could be investigated using Calcium Orange.  This 
marker carries a fluorescent tag that is activated once it passes into the membrane of a 
cell. By comparing Calcium Orange fluorescent values between control and NMDA 
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exposed slices, NMDA receptor activity could be determined, although it would not be 
selective for NR2B containing receptors. 
In conclusion, the current research provides a temporal and topographical map of 
the progression of excitotoxic neurodegeneration.  The data reveal that initial injury is 
evident in the soma.  However, even after the occurrence of this significant damage, 
distal regions of the cell are still engaging regulatory mechanisms in an effort to stop the 
excitatory signal.  This information could aid future research in developing therapies to 
diminish neurodegeneration resulting from excitotoxicity. 
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